Janus Henderson Group
Overview
Janus Henderson Group is a global asset management firm formed through the 2017 merger of Janus Capital Group and Henderson Group, offering a range of financial products across equities, fixed income, multi-asset, and alternatives to individuals, intermediary advisors, and institutional investors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| BioNTech SE | Jul 2019 | Series B | Co-investor |
| Metsera | Nov 2024 | Series B | Co-investor |
| CesiumAstro | Nov 2026 | Series D | Lead |
| Voyager Technologies | Jun 2025 | IPO | Co-investor |
| Everest Medicines | Jun 2020 | Series C | Co-investor |
For institutional investors. Book with your work email.
Key People
Amy J. Boyle
Senior People Business Partner
Myron Scholes
Chief Investment Strategist
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Janus Henderson Group based?
Janus Henderson Group is headquartered in London, Colorado, United Kingdom.
When was Janus Henderson Group founded?
Janus Henderson Group was founded in 1934.
How many portfolio companies does Janus Henderson Group have?
Janus Henderson Group has 123 portfolio companies in Caplight's dataset.
What are some companies in Janus Henderson Group's portfolio?
Portfolio companies visible on Caplight include BioNTech SE, Metsera, CesiumAstro, Voyager Technologies, Everest Medicines.
What was Janus Henderson Group's most recent investment shown here?
Janus Henderson Group's most recent investment in this portfolio sample was in CesiumAstro in 2026.
What sectors does Janus Henderson Group focus on?
Janus Henderson Group focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Real Estate & PropTech, FinTech, Crypto & Web3, Mobility, Transportation & Logistics, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Consumer & Commerce, Mobility, Transportation & Logistics, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, FinTech, Healthcare & Life Sciences, Frontier & Industrial Tech, Crypto & Web3, Consumer & Commerce, Enterprise Software, Enterprise Software, Frontier & Industrial Tech, Enterprise Software, FinTech, Crypto & Web3, AI, Data & Cloud Infrastructure, Enterprise Software, Telecommunications & Networking, Enterprise Software, Frontier & Industrial Tech, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Telecommunications & Networking, Consumer & Commerce, Enterprise Software, Crypto & Web3, Enterprise Software, Consumer & Commerce, Enterprise Software, Media, Entertainment & Gaming, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, FinTech, AI, Data & Cloud Infrastructure, Mobility, Transportation & Logistics, Energy & Sustainability, Frontier & Industrial Tech, Consumer & Commerce, Frontier & Industrial Tech.
What company stages does Janus Henderson Group focus on?
Janus Henderson Group typically invests at the MultiStage stage.
What is Janus Henderson Group's AUM?
Janus Henderson Group's assets under management are estimated between $379.0B and $493.0B.